Article info

PDF
PP-41 Risk assessment for compatibility of rhigf-1/rhigfbp-3 with commonly administered neonatal intravenous medications based on an experimental model

Authors

Citation

Turner, Bandekar, Barton, et al
PP-41 Risk assessment for compatibility of rhigf-1/rhigfbp-3 with commonly administered neonatal intravenous medications based on an experimental model

Publication history

  • First published September 20, 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.